Symptomtext
no additional Adverse event; The medical assistant could not rule out that the imrpoperly stored vaccines, PEDAVX HIB, VAQTA and ROTATEQ were administered to patients.; This spontaneous report was received from a medical assistant and refers to an unspecified number of patients of unknown age and gender. The patients medical history, concurrent conditions and concomitant therapies were not reported. Between the week of 11-JUL-2022 and 15-JUL-2022, there was a temperature excursion with the lowest temperature at 0.92?C, of 11 hours and 30 minutes of the following vaccines: haemophilus b conjugate vaccine (meningococcal protein conjugate) (LIQUID PEDVAXHIB), lot #U024091, expiration date: 29-OCT-2023, and lot#batch# W000458, expiration date: 17-JUN-2024 administered to prevent haemophilis influenza B infection (formulation, strength, and route of administration were not provided); rotavirus vaccine, live, oral, pentavalent (ROTATEQ) lot #1742419, expiration date: 23-JAN-2023, and lo#/batch# W004503, expiration date: 15-MAY-2023, administered to prevent rotavirus infection (formulation, strength, and route of administration were not provided); hepatitis a vaccine, inactivated (VAQTA) lot #U033212, expiration date: 07-NOV-2022, administered to prevent hepatitis A infection (formulation, strength, and route of administration were not provided); and hepatitis a vaccine, inactivated (VAQTA) lot #W002889, expiration date: 06-MAR-2023, administered to prevent hepatitis A infection (formulation, strength, and route of administration were not provided). The reporter could not rule out that the improperly stored vaccines were administered to patients on an unknown date in July 2022. (Improper storage of product in use). There were no additional adverse events reported (no adverse event). This is a non-valid case due to lack of patient's identifiers.